Abacus ALS, a privately-owned distributor of diagnostic pathology and medical research solutions based in East Brisbane, is currently growing at five times the industry rate. Beginning as a one-person operation the company now has offices in four Australian states and New Zealand and its customers include public and private laboratories, blood services and university research departments.
The company’s sound business strategy and focused expansion plan were behind Telstra’s decision to award it top honours, says Telstra Business Group Managing Director and Ambassador of the Telstra Business Awards Deena Shiff.
“Judges said Abacus ALS is a great business demonstrating excellence across all its core functions with clear strategies for achievement and a culture of strong and passionate employee engagement”
“It is growing ahead of its rivals in an environment and industry of substantial competitiveness and focus on procurement-driven decisions. It has an independent corporate advisory board that ensures ongoing professional governance for the business,” Ms Shiff added.
Abacus ALS, formed by a merger of Abacus Diagnostics and Australian Laboratory Services in 2007, provides internationally-manufactured products for clinical diagnostics in critical care, allergy and autoimmunity, bone and mineral testing, infectious serology and life science.
Abacus Diagnostics was founded by Bruce Evans in 1998 after he identified a gap for an Australian-owned distributor of in vitro diagnostic pathology and research products in a market dominated by a few multinational companies. In 2007 the company acquired Australian Laboratory Services and was re-branded as Abacus ALS.